These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17651869)

  • 1. On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
    Salmon E; Kerrouche N; Perani D; Lekeu F; Holthoff V; Beuthien-Baumann B; Sorbi S; Lemaire C; Collette F; Herholz K
    Neurobiol Aging; 2009 Feb; 30(2):186-97. PubMed ID: 17651869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    Kerrouche N; Herholz K; Mielke R; Holthoff V; Baron JC
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1213-21. PubMed ID: 16525414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.
    Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K
    Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.
    Desgranges B; Baron JC; de la Sayette V; Petit-Taboué MC; Benali K; Landeau B; Lechevalier B; Eustache F
    Brain; 1998 Apr; 121 ( Pt 4)():611-31. PubMed ID: 9577389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease.
    Salmon E; Lekeu F; Garraux G; Guillaume B; Magis D; Luxen A; Moonen G; Collette F
    Neurobiol Aging; 2008 Dec; 29(12):1823-9. PubMed ID: 17543421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional imaging of cognition in Alzheimer's disease using positron emission tomography.
    Salmon E; Lekeu F; Bastin C; Garraux G; Collette F
    Neuropsychologia; 2008; 46(6):1613-23. PubMed ID: 18191961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain
    Van Der Gucht A; Aoun Sebaiti M; Guedj E; Aouizerate J; Yara S; Gherardi RK; Evangelista E; Chalaye J; Cottereau AS; Verger A; Bachoud-Levi AC; Abulizi M; Itti E; Authier FJ
    J Nucl Med; 2017 Mar; 58(3):492-498. PubMed ID: 27765861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA; Monserratt L; Harwood D; Mandelkern M; Cummings JL; Sultzer DL
    Arch Neurol; 2007 Jul; 64(7):1015-20. PubMed ID: 17620493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.
    Matías-Guiu JA; Pytel V; Cabrera-Martín MN; Galán L; Valles-Salgado M; Guerrero A; Moreno-Ramos T; Matías-Guiu J; Carreras JL
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2050-60. PubMed ID: 27262702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography.
    Huang YC; Yen PS; Wu ST; Chen JT; Hung GU; Kao CH; Chen TY; Ho FM
    Medicine (Baltimore); 2015 Jul; 94(30):e1252. PubMed ID: 26222866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
    Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
    Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism.
    Georgiou MF; Gonenc A; Waldrop-Valverde D; Kuker RA; Ezuddin SH; Sfakianakis GN; Kumar M
    J Nucl Med; 2008 Dec; 49(12):1999-2005. PubMed ID: 18997046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data.
    Pagani M; Giuliani A; Öberg J; Chincarini A; Morbelli S; Brugnolo A; Arnaldi D; Picco A; Bauckneht M; Buschiazzo A; Sambuceti G; Nobili F
    Neuroimage; 2016 Nov; 141():282-290. PubMed ID: 27453158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
    Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
    J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.